The effect of anti-inflammatory treatment on bacterial rhino-sinusitis in a murine model Source: Eur Respir J 2002; 20: Suppl. 38, 618s Year: 2002
The inhibitory effect of ciprofloxacin on bacterial adhesiveness is enhanced by the SH-metabolite I of erdosteine (mucolytic drug) Source: Eur Respir J 2001; 18: Suppl. 33, 543s Year: 2001
Comparison of immunomodulating effects among clarithromycin, dexamethasone and levofloxacin on the murine model of mycoplasma pneumoniae pneumonia Source: Annual Congress 2008 - Advances in the treatment and pathogenesis of pulmonary diseases Year: 2008
Immunomodulating effect of clarithromycin in a murine model of mycoplasma pneumoniae pneumonia Source: Eur Respir J 2007; 30: Suppl. 51, 737s Year: 2007
Intracellular accumulation and bactericidal activity of moxifloxacin and ciprofloxacin in primary respiratory epithelial cells Source: Eur Respir J 2002; 20: Suppl. 38, 91s Year: 2002
Effects of PC945, a novel antifungal agent optimised for lung delivery, on Candida albicans lung infection in mice Source: Virtual Congress 2020 – Translational science in respiratory infections Year: 2020
Synthetic peptide gamma-D-Glutaminyl-L-Tryptophan has antituberculosis activity in murine model Source: Eur Respir J 2001; 18: Suppl. 33, 340s Year: 2001
The JAK3 inhibitor CP-690550 is a potent anti-fibrosis agent in a murine model of pulmonary fibrosis induced by bleomycin Source: Annual Congress 2012 - Idiopathic pulmonary fibrosis Year: 2012
Azithromycin protects bronchial epithelial integrity after Pseudomonas aeruginosa infection independent of bactericidal activity Source: Annual Congress 2008 - Best of lung epithelial cells 2008 Year: 2008
Airway administration of therapeutic antibody (tAb) confers higher protection than parenteral administration in a murine model of acute lung infection Source: International Congress 2018 – New therapies for respiratory infections: experimental and translational studies Year: 2018
Potential synergism of drugs with anti-viral and pulmonary oedema clearance activity may be advantageous for influenza patients Source: Annual Congress 2011 - Insight into mechanisms of respiratory infections Year: 2011
The inhibitory effect of salbutamol on neutrophil's respiratory burst is enhanced by the SH-metabolite of erdosteine (mucoactive drug) Source: Eur Respir J 2002; 20: Suppl. 38, 617s Year: 2002
Effect of low-dose aspirin in a murine model of active tuberculosis Source: International Congress 2017 – Human susceptibility to tuberculosis Year: 2017
Effects of direct lung dosing of Tobramycin in a rat chronic infection model using Pseudomonas aeruginosa RP73 Source: International Congress 2018 – Mechanisms of respiratory infection Year: 2018
Biological resistance to beta-lactamic antibiotics in patients with respiratory infection in the prediction of efficiency of antibacterial therapy Source: Virtual Congress 2020 – Lower respiratory tract infections in clinical practice Year: 2020
Defining optimal fluoroquinolone exposure against Mycobacterium tuberculosis : contribution of murine studies Source: Eur Respir J, 57 (4) 2004315; 10.1183/13993003.04315-2020 Year: 2021
Immunomodulatory effects of moxifloxacin in human respiratory tract infection Source: Annual Congress 2010 - Treatment and risk factors in lower respiratory tract infections Year: 2010
The combination of budesonide and formoterol exerts more rapid and enhanced anti-inflammatory effects than either drug alone in rat lungs in vivo Source: Eur Respir J 2004; 24: Suppl. 48, 344s Year: 2004
Antituberculosis activity of rifabutin in vitro and in patients with pulmonary drug resistant tuberculosis Source: Eur Respir J 2003; 22: Suppl. 45, 524s Year: 2003
Intratracheally administered recombinant adenovirus carrying a novel mutated IκBα gene abrogates pulmonary eosinophil inflammation in a murine asthma model Source: Eur Respir J 2006; 28: Suppl. 50, 225s Year: 2006